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The thing that goes the farthest towards making life worthwhile, 
 That does the most and costs the least, is just a pleasant smile 
       - A friend of Gigi’s 
I first read this quote in an autograph book of my grandmother Gigi’s and it has stuck 
with me ever since.  After a quick Google search, I now know it was originally written by 
Wilbur Nesbit.  Anyone who works with me knows I usually have a smile on my face.  
My experiences at Caltech have brought many smiles to my face.  For that, I have many 
people to thank! 
I would like to thank my advisor, Dennis Dougherty.  Without asking any questions, 
he accepted me into his group after candidacy my second year.  I could not ask for a 
better mentor than Dennis.  He shows a genuine interest in his students both on a 
professional level and on a personal level.  Even without the kind words from his wife, 
Ellen, it is evident that Dennis truly enjoys working with students and being a teacher.  
His broad scientific knowledge and his ability to interpret experimental results amaze me.  
I appreciate his support in giving me the freedom to explore professional growth 
opportunities both inside and outside of lab. 
It has been nice to work with Henry Lester as well.  Collaborations with the Lester 
group have taught me a lot about biology and about the importance of analyzing every 
bump on an electrophysiology trace.  I would also like to thank my thesis committee, 
Linda Hsieh-Wilson, David Tirrell, and Doug Rees, for their time and commitment.   
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Daily life at Caltech was also enjoyable because of the members of the Dougherty 
Lab.  From home-made group videos, to chair races, to Strong Bad e-mails, to fantasy 
sports, to the matching game, there was always welcomed entertainment in lab.  When I 
first joined the lab, the friendly personalities of Niki Zacharias and Sarah May made me 
feel right at home.  Josh Maurer and Gabe Brandt helped me catch up to speed by 
teaching me lab techniques and showing me the importance of picking good projects.  
James Petersson and Darren Beene taught me a lot about experiments as well.  James’s 
passion for science and his ambitious goals are inspiring.  I also enjoyed getting to know 
Darren and his adorable family.  The lab post-doc, David Dahan, was also a great 
resource for any electrophysiology advice.  I always enjoyed working with Don Elmore 
and I truly miss his music selections in lab.  It has been a lot of fun working with Steve 
Spronk as well.  I will always remember his excitement about his courtship of his now 
wife, Tiffany.  Tingwei Mu is a kind and generous person and I know he will continue to 
do great things in life.   
The current Dougherty group members are continuing the lab spirit.  Lori Lee, a 
fellow defector to the lab, makes a great chocolate cake.  I wish this California girl the 
best of luck during the Michigan winters of her post-doc.  Erik Rodriguez will 
undoubtedly continue to improve the lab methodology.  It has been a pleasure 
collaborating with Mike Torrice the past few months.  His ability to crack himself up 
always makes me smile.  I have enjoyed getting to know Amy Eastwood.  Her 
commitments to running and to “The Best Team Ever” are motivational.  The lab is also 
lucky to have Katie McMenimen around.  Her love of science is evident and I have 
enjoyed becoming friends with her the past few years.  Joanne Xiu is very energetic and 
fun to be around.  Her ability to learn new techniques will undoubtedly advance the lab.  
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Kiowa Bower has also been fun to get to know.  After getting used to his personal style, I 
have really enjoyed our conversations and his passion for the mountains.  I can easily 
sleep at night knowing that Ariele Hanek is taking good care of the Opus.  Kristin Rule’s 
energy, as evidenced by her role as the ultimate Caltech Chemistry Cheerleader, will 
continue to bring her success during her studies at Caltech.  Jinti Wang will surely 
continue to hold the record for the highest number of mutations studied in the lab.  Jai 
Shanata and Kay Limapichat are welcomed newcomers to the lab.  Jai is bravely taking 
on single cannel studies that will undoubtedly add depth to our research.  I would also 
like to thank members of the Lester Lab.  Rigo Pantoja, Purnima Deshpande, Nivalda 
Pinguet, Stephanie Huang, John Leite, and Fraser Moss have been great resources and a 
pleasure to work with.   
I am also thankful for the time that I spent in Peter Dervan’s lab my first two years at 
Caltech.  Peter’s enthusiasm and his energy are unlike any other.  Clay Wang, Doan 
Nguyen, and Eric Fechter made my time in the lab more enjoyable and I am thankful for 
their advice and support.  I am thankful for Clay, my first mentor at Caltech, for teaching 
me molecular biology skills and how to run the perfect gel.  Doan, pursuing a career at 
the interface of science and business, remains a role model for me today.  Eric is the ideal 
classmate and friend.  Another classmate, Ben Edelson was also important to me.  I will 
always remember my collaboration with Ben and his joy of sharing his knowledge with 
others.  He is missed. 
Outside of lab, I have had the opportunity to make great friends and to experience 
Caltech beyond my research experience.  My friendship with Jessica Mao has extended 
from TA’ing, to research collaborations, and to a terrific partnership in leading the 
Caltech Biotech Club.  Xin Qi, Christie Morrill, and Anand Vadehra have also become 
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great friends.  The relationships I have built and the exposure that I have gained from my 
experiences with the Caltech Biotech Club are invaluable.  I am grateful to the club 
founders, Dee Datta and Jessica Mao, for bringing this long-needed club to Caltech.  
I save my final thanks for my family.  The continued encouragement of my parents 
and their value of education brought me to where I am today.  I thank my grandparents 
for their support.  I thank my mother for her love and support.  I thank my big-sister 
Diane and brother-in-law Marcus for their love and encouragement.  I thank Pete Choi 
whose love and friendship continues to make me smile.  I look forward to sharing our 
futures together.       
       
                                       
 










Biological signaling pathways employ a vast array of integral membrane proteins that 
process and interpret the chemical, electrical, and mechanical signals that are delivered to 
cells.  Among these proteins, ligand gated ion channels (LGIC) are therapeutic targets for 
Alzheimer’s disease, Schizophrenia, drug addiction, and learning and memory.  High-
resolution structural data on neuroreceptors are only just becoming available, yet the 
functional importance of particular structural features can be challenging.   
The primary focus of the present work is to gain a chemical scale understanding of 
the ligand-receptor binding determinants of LGICs.  In particular, these studies explore 
drug-receptor interactions at the nicotinic acetylcholine receptor (nAChR), the most 
extensively studied members of the Cys-loop family of LGICs.  The present study 
utilizes in vivo nonsense suppression methodology to perform chemical scale 
investigations of nAChR agonist activity.   
The binding of three distinct agonists–acetylcholine (ACh), nicotine, and epibatidine-
to the nicotinic acetylcholine receptor (nAChR) has been probed using unnatural amino 
acid mutagenesis.  ACh makes a cation-π interaction with Trp α149, while nicotine 
employs a hydrogen bond to a backbone carbonyl in the same region of the agonist 
binding site.  The nicotine analogue epibatidine achieves its high potency by taking 
advantage of both the cation-π interaction and the backbone hydrogen bond.  
Nonsense suppression was also utilized to probe the importance of residues outside of 
the binding box in nAChR function.  These studies demonstrate a structural role of the 
highly conserved αD89 residue in stabilizing the agonist binding site near αW149.  In 
addition to outer shell residue, αK145 is shown to be important for proper nAChR 
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function.  In combination with additional evidence from other recent advances, this site is 
proposed to be important in initiating the nAChR channel gating pathway.  
Residues outside the aromatic binding site were also examined through computational 
protein design studies.  Results from these studies identify outer shell mutations 116Q 
and 57R (AChBP numbering) that enhance nAChR specificity for nicotine, over ACh and 
epibatidine compared to wild-type receptors. 
Finally, a series of cationic polyamides were shown to enhance polyamide affinity 
while maintaining specificity by varying the number, relative spacing, and linker length 
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